0      0


SUN05 - Hereditary Cancer Considerations in Transgender and Gender Diverse Patients


‐ May 7, 2023 10:00am

2.0 CE credits/hours

This workshop addresses approaches to delivering high-quality cancer care for transgender patients.


Learning Objectives:

  • Define important terms and concepts in caring for LGBTQ patients
  • Summarize common treatments used for transgender and gender diverse (TGD) patients
  • Review what is known about relative cancer risks in the TGD population
  • Examine how aspects of transgender care could change management of hereditary cancer syndromes

Speaker(s):

Tags:

CE session Pharmacology Credit

You must be logged in and own this session in order to post comments.